Literature DB >> 26199340

Racial and Ethnic Disparity in Symptomatic Breast Cancer Awareness despite a Recent Screen: The Role of Tumor Biology and Mammography Facility Characteristics.

Mylove Mortel1, Garth H Rauscher2, Anne Marie Murphy3, Kent Hoskins4, Richard B Warnecke5.   

Abstract

BACKGROUND: In a racially and ethnically diverse sample of recently diagnosed urban patients with breast cancer, we examined associations of patient, tumor biology, and mammography facility characteristics on the probability of symptomatic discovery of their breast cancer despite a recent prior screening mammogram.
METHODS: In the Breast Cancer Care in Chicago study, self-reports at interview were used to define patients as having a screen-detected breast cancer or having symptomatic awareness despite a recent screening mammogram (SADRS), in the past 1 or 2 years. Patients with symptomatic breast cancer who did not report a recent prior screen were excluded from these analyses. Characteristics associated with more aggressive disease [estrogen receptor (ER)- and progesterone receptor (PR)-negative status and higher tumor grade] were abstracted from medical records. Mammogram facility characteristics that might indicate aspects of screening quality were defined and controlled for in some analyses.
RESULTS: SADRS was more common among non-Hispanic black and Hispanic than among non-Hispanic white patients (36% and 42% vs. 25%, respectively, P = 0.0004). SADRS was associated with ER/PR-negative and higher-grade disease. Patients screened at sites that relied on dedicated radiologists and sites that were breast imaging centers of excellence were less likely to report SADRS. Tumor and facility factors together accounted for two thirds of the disparity in SADRS (proportion mediated = 70%, P = 0.02).
CONCLUSION: Facility resources and tumor aggressiveness explain much of the racial/ethnic disparity in symptomatic breast cancer among recently screened patients. IMPACT: A more equitable distribution of high-quality screening would ameliorate but not eliminate this disparity. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26199340      PMCID: PMC4592461          DOI: 10.1158/1055-9965.EPI-15-0305

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  40 in total

1.  Improving the accuracy of mammography: volume and outcome relationships.

Authors:  Laura Esserman; Helen Cowley; Carey Eberle; Alastair Kirkpatrick; Sophia Chang; Kevin Berbaum; Alastair Gale
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

2.  Complementary approaches to assessing risk factors for interval breast cancer.

Authors:  Jan T Lowery; Tim Byers; John E Hokanson; John Kittelson; John Lewin; Betsy Risendal; Meenakshi Singh; Judy Mouchawar
Journal:  Cancer Causes Control       Date:  2010-10-27       Impact factor: 2.506

Review 3.  Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.

Authors:  Anna M Chiarelli; Sarah A Edwards; Amanda J Sheppard; Lucia Mirea; Nelson Chong; Lawrence Paszat; Rene S Shumak; Frances P Oʼmalley
Journal:  Eur J Cancer Prev       Date:  2012-11       Impact factor: 2.497

4.  Self-detection remains a key method of breast cancer detection for U.S. women.

Authors:  Mara Y Roth; Joann G Elmore; Joyce P Yi-Frazier; Lisa M Reisch; Natalia V Oster; Diana L Miglioretti
Journal:  J Womens Health (Larchmt)       Date:  2011-06-15       Impact factor: 2.681

5.  Disparities in screening mammography services by race/ethnicity and health insurance.

Authors:  Garth H Rauscher; Kristi L Allgood; Steve Whitman; Emily Conant
Journal:  J Womens Health (Larchmt)       Date:  2011-09-23       Impact factor: 2.681

6.  Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.

Authors:  P L Porter; A Y El-Bastawissi; M T Mandelson; M G Lin; N Khalid; E A Watney; L Cousens; D White; S Taplin; E White
Journal:  J Natl Cancer Inst       Date:  1999-12-01       Impact factor: 13.506

7.  Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States).

Authors:  R J Coates; R J Uhler; D J Brogan; M D Gammon; K E Malone; C A Swanson; E W Flagg; L A Brinton
Journal:  Cancer Causes Control       Date:  2001-06       Impact factor: 2.506

8.  Method of detection of breast cancer in low-income women.

Authors:  Amardeep Thind; Allison Diamant; Lalima Hoq; Rose Maly
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

9.  Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.

Authors:  Laia Domingo; Jordi Blanch; Sònia Servitja; Josep Maria Corominas; Cristiane Murta-Nascimento; Antonio Rueda; Maximino Redondo; Xavier Castells; Maria Sala
Journal:  Eur J Cancer Prev       Date:  2013-01       Impact factor: 2.497

10.  Detection methods predict differences in biology and survival in breast cancer patients.

Authors:  Maximino Redondo; Rafael Funez; Francisco Medina-Cano; Isabel Rodrigo; Mercedes Acebal; Teresa Tellez; M Jose Roldan; M Luisa Hortas; Ana Bellinvia; Teresa Pereda; Laia Domingo; María Morales-Suarez Varela; Maria Sala; Antonio Rueda
Journal:  BMC Cancer       Date:  2012-12-17       Impact factor: 4.430

View more
  11 in total

1.  Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.

Authors:  Garth H Rauscher; Abigail Silva; Heather Pauls; Jonna Frasor; Marcelo G Bonini; Kent Hoskins
Journal:  Breast Cancer Res Treat       Date:  2017-03-01       Impact factor: 4.872

2.  Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.

Authors:  Sarah J Nyante; Linn Abraham; Erin J Aiello Bowles; Christoph I Lee; Karla Kerlikowske; Diana L Miglioretti; Brian L Sprague; Louise M Henderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

3.  Multilevel Examination of Health Disparity: The Role of Policy Implementation in Neighborhood Context, in Patient Resources, and in Healthcare Facilities on Later Stage of Breast Cancer Diagnosis.

Authors:  Richard B Warnecke; Richard T Campbell; Ganga Vijayasiri; Richard E Barrett; Garth H Rauscher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-23       Impact factor: 4.254

4.  Absence of an anticipated racial disparity in interval breast cancer within a large health care organization.

Authors:  Garth H Rauscher; Firas Dabbous; Therese A Dolecek; Sarah M Friedewald; Katherine Tossas-Milligan; Teresita Macarol; W Thomas Summerfelt
Journal:  Ann Epidemiol       Date:  2017-09-20       Impact factor: 3.797

5.  Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.

Authors:  Andreana N Holowatyj; Michele L Cote; Julie J Ruterbusch; Kristina Ghanem; Ann G Schwartz; Fawn D Vigneau; David H Gorski; Kristen S Purrington
Journal:  J Clin Oncol       Date:  2018-01-17       Impact factor: 44.544

6.  Initial Point of Entry to the Health Care System May Affect Downstream Quality of Breast Cancer Care.

Authors:  Garth H Rauscher; Yamilé Molina; Abigail Silva; Anne Marie Murphy
Journal:  J Am Coll Radiol       Date:  2021-07-08       Impact factor: 6.240

7.  Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.

Authors:  Brittany D Jenkins; Rachel N Martini; Rupali Hire; Andrea Brown; Briana Bennett; I'nasia Brown; Elizabeth W Howerth; Mary Egan; Jamie Hodgson; Clayton Yates; Rick Kittles; Dhananjay Chitale; Haythem Ali; David Nathanson; Petros Nikolinakos; Lisa Newman; Michele Monteil; Melissa B Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-04       Impact factor: 4.090

8.  Changes in the racial disparity in breast cancer mortality in the ten US cities with the largest African American populations from 1999 to 2013: The reduction in breast cancer mortality disparity in Chicago.

Authors:  Dominique Sighoko; Anne Marie Murphy; Bethliz Irizarry; Garth Rauscher; Carol Ferrans; David Ansell
Journal:  Cancer Causes Control       Date:  2017-03-08       Impact factor: 2.506

9.  Determinants of cancer screening awareness and participation among Indonesian women.

Authors:  Sumadi L Anwar; Gindo Tampubolon; Mieke Van Hemelrijck; Susanna H Hutajulu; Johnathan Watkins; Wahyu Wulaningsih
Journal:  BMC Cancer       Date:  2018-03-06       Impact factor: 4.430

10.  Breast Cancer Disparities Among Women in Underserved Communities in the USA.

Authors:  Beti Thompson; Sarah D Hohl; Yamile Molina; Electra D Paskett; James L Fisher; Ryan D Baltic; Chasity M Washington
Journal:  Curr Breast Cancer Rep       Date:  2018-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.